A Cognitive Behavioral Digital Therapeutic InterventiON for Glycemic Control in Type 2 Diabetes Mellitus

NAActive, not recruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

March 7, 2022

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Diabetes Type 2
Interventions
DEVICE

BT-001

"BT-001is a software application that delivers treatment to participants with type 2 diabetes, using behavioral therapy. BT-001 is accessed via the participants' smartphone.~The behavioral intervention process involves:~Identifying maladaptive thoughts based on misinformed core beliefs that lead to disease-promoting behaviors; replacing maladaptive core beliefs with adaptive ways of thinking; and providing collaborative construction of behavioral exercises to test core beliefs.~Each week, BT-001 asks participants to complete a new lesson, along with one skill exercise. The lessons are expected to take between 10-20 minutes to complete. In addition to completing a lesson and skill, participants will be directed to report plant-based meals consumed and minutes of exercise completed and to measure their blood sugar daily."

DEVICE

Control Mobile Application

The app asks patients brief questions about their health but does not include any behavioral therapy.

Trial Locations (1)

02199

Mass General Brigham Hospital and Clinics, Boston

Sponsors
All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

lead

Better Therapeutics

INDUSTRY